CN111084900A - Preparation method and application of acellular fish skin matrix - Google Patents
Preparation method and application of acellular fish skin matrix Download PDFInfo
- Publication number
- CN111084900A CN111084900A CN201811232737.0A CN201811232737A CN111084900A CN 111084900 A CN111084900 A CN 111084900A CN 201811232737 A CN201811232737 A CN 201811232737A CN 111084900 A CN111084900 A CN 111084900A
- Authority
- CN
- China
- Prior art keywords
- washing
- solution
- fish skin
- acellular
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000251468 Actinopterygii Species 0.000 title claims abstract description 58
- 239000011159 matrix material Substances 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title abstract description 6
- 238000005406 washing Methods 0.000 claims abstract description 22
- 206010052428 Wound Diseases 0.000 claims abstract description 20
- 208000027418 Wounds and injury Diseases 0.000 claims abstract description 20
- 241000276707 Tilapia Species 0.000 claims abstract description 15
- 230000001954 sterilising effect Effects 0.000 claims abstract description 14
- 230000029663 wound healing Effects 0.000 claims abstract description 12
- 239000000126 substance Substances 0.000 claims abstract description 9
- 239000004094 surface-active agent Substances 0.000 claims abstract description 9
- 239000003513 alkali Substances 0.000 claims abstract description 7
- 239000007844 bleaching agent Substances 0.000 claims abstract description 7
- 238000010306 acid treatment Methods 0.000 claims abstract description 6
- 239000012535 impurity Substances 0.000 claims abstract description 6
- 238000007790 scraping Methods 0.000 claims abstract description 6
- 238000001035 drying Methods 0.000 claims abstract description 3
- 239000000243 solution Substances 0.000 claims description 35
- 238000000034 method Methods 0.000 claims description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 15
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical group [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 12
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 238000002791 soaking Methods 0.000 claims description 9
- 238000004659 sterilization and disinfection Methods 0.000 claims description 8
- 230000001737 promoting effect Effects 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 claims description 6
- 230000002500 effect on skin Effects 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 230000010355 oscillation Effects 0.000 claims description 6
- 239000011780 sodium chloride Substances 0.000 claims description 6
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 5
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- 229960003964 deoxycholic acid Drugs 0.000 claims description 4
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 claims description 4
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 3
- 229920004890 Triton X-100 Polymers 0.000 claims description 3
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 3
- 239000007853 buffer solution Substances 0.000 claims description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 3
- 229920000053 polysorbate 80 Polymers 0.000 claims description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- 239000012267 brine Substances 0.000 claims description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 claims description 2
- 241000700605 Viruses Species 0.000 abstract description 8
- 238000005516 engineering process Methods 0.000 abstract description 4
- 230000002779 inactivation Effects 0.000 abstract description 4
- 238000003892 spreading Methods 0.000 abstract description 4
- 230000007480 spreading Effects 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 244000144972 livestock Species 0.000 abstract 1
- 102000008186 Collagen Human genes 0.000 description 11
- 108010035532 Collagen Proteins 0.000 description 11
- 229920001436 collagen Polymers 0.000 description 11
- 241000276438 Gadus morhua Species 0.000 description 10
- 241000700159 Rattus Species 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- 238000011160 research Methods 0.000 description 6
- 238000004061 bleaching Methods 0.000 description 5
- 230000035876 healing Effects 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 238000004108 freeze drying Methods 0.000 description 4
- 238000002513 implantation Methods 0.000 description 4
- 238000010186 staining Methods 0.000 description 4
- 241000316887 Saissetia oleae Species 0.000 description 3
- 239000012670 alkaline solution Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 238000001878 scanning electron micrograph Methods 0.000 description 3
- 238000009777 vacuum freeze-drying Methods 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- GUTLYIVDDKVIGB-OUBTZVSYSA-N Cobalt-60 Chemical compound [60Co] GUTLYIVDDKVIGB-OUBTZVSYSA-N 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- 241000276701 Oreochromis mossambicus Species 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 239000000515 collagen sponge Substances 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000005714 functional activity Effects 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000028709 inflammatory response Effects 0.000 description 2
- 229940127554 medical product Drugs 0.000 description 2
- 239000008055 phosphate buffer solution Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 2
- OCKGFTQIICXDQW-ZEQRLZLVSA-N 5-[(1r)-1-hydroxy-2-[4-[(2r)-2-hydroxy-2-(4-methyl-1-oxo-3h-2-benzofuran-5-yl)ethyl]piperazin-1-yl]ethyl]-4-methyl-3h-2-benzofuran-1-one Chemical compound C1=C2C(=O)OCC2=C(C)C([C@@H](O)CN2CCN(CC2)C[C@H](O)C2=CC=C3C(=O)OCC3=C2C)=C1 OCKGFTQIICXDQW-ZEQRLZLVSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 208000031295 Animal disease Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 208000007212 Foot-and-Mouth Disease Diseases 0.000 description 1
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
- 206010024769 Local reaction Diseases 0.000 description 1
- 239000007987 MES buffer Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010029113 Neovascularisation Diseases 0.000 description 1
- 240000007711 Peperomia pellucida Species 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000018756 Variant Creutzfeldt-Jakob disease Diseases 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 208000005881 bovine spongiform encephalopathy Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 238000000113 differential scanning calorimetry Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
- 206010048282 zoonosis Diseases 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a preparation method of a novel acellular fish skin matrix, which comprises the following steps: 1) washing tilapia skin to remove impurities and other pretreatment; 2) scraping off the scale coat after acid treatment; 3) washing with a surfactant to remove cells; 4) washing with alkali liquor; 5) chemical bleaching agent treatment; 6) drying and sterilizing. The acellular fish skin matrix prepared by the invention has the advantages of low production cost, high thermal stability, no risk of spreading viruses shared by human and livestock and the like, and creatively provides a scale coat removing technology, so that the clinical practicability of the product is greatly improved; and various technologies are comprehensively applied to carry out virus inactivation, thereby improving the biological safety of the product. The invention also discloses application of the acellular fish skin matrix as a wound dressing, which can promote wound healing and epithelization of new tissues.
Description
Technical Field
The invention belongs to the field of biomedical materials, and relates to a preparation method of a novel acellular fish skin matrix material and application of the acellular fish skin matrix material as a wound dressing.
Background
The correct treatment of the surgical wound is one of the keys of success and failure of surgical operation treatment, and the good healing of the wound is the premise of the recovery of the body function after the wound, so that the research for accelerating the healing of the wound is very important, and the research on the wound dressing is one of the hot spots of the research. With the progress of wound healing research, it is recognized that the purpose of using a dressing is far beyond covering the wound surface, and that the dressing must also aid in wound healing. The development of functional dressings with wound healing promoting or hemostatic activity has therefore become a focus of current research. At present, the wound dressings clinically used in China have more brands, but according to clinical feedback, the nationwide recognition of better hemostasis effect is strong 'fast-growing yarn', but the wound dressings have no functional activity of promoting healing; the acellular dermal matrix or collagen sponge dressing with good healing promoting effect has the effects of hemostasis, tissue repair, healing promotion and the like, and is widely applied clinically, such as bovine-derived collagen sponge, porcine-derived acellular dermal matrix and the like.
A large number of studies and clinical practices show that collagen has good biocompatibility and wound healing promoting activity. However, mammalian collagen still carries the risk of transmitting animal diseases, such as bovine spongiform encephalopathy and foot and mouth disease. In addition, the use of mammalian collagen has been limited for religious reasons. In recent years, aquatic collagen has attracted attention because of its abundance and low cost.
The number of fish collagen medical products which are clinically used at present is small, and the acellular fish skin matrix Kerecis approved by FDA in 2013TMTakes Atlantic cod as raw materialThe dressing is developed by adopting the patent technology of WO 2011/042794 and is mainly used as a dressing for the wound surface of chronic ulcer. In WO 2011/042794, the method comprises removing impurities from fish skin, cleaning, soaking in sterile PBS containing 50mM ascorbic acid and 500ppm streptomycin to stabilize the three-dimensional structure in matrix, removing cells with deoxycholic acid (or SDS and Triton X-100), digesting with Tris-HCl/trypsin mixed solution, treating with pre-freezing solution, freeze drying, and sterilizing with ethylene oxide.
However, large-scale artificial culture of cod is not realized at present, the traceability of raw materials of wild cod is poor, so that the raw materials for preparing medical products by using cod as a raw material are very limited, and the thermal stability of collagen of cod as a deep-sea fish is poor. In addition, the production process described in WO 2011/042794 is tedious and does not include virus inactivation process steps, so that development of a clean fish collagen product that has a large supply of raw materials and thermal stability and is close to mammals is a problem to be solved in the current fish collagen industrialization.
Disclosure of Invention
The invention aims to research a novel preparation method of acellular fish skin matrix by using tilapia skin as a raw material, and verify the performance of the acellular fish skin matrix as wound dressing.
The invention discloses a method for preparing a tilapia skin acellular dermal matrix, which specifically comprises the following steps:
1) washing tilapia skin to remove impurities and other pretreatment;
2) scraping off the scale coat after acid treatment;
3) washing with a surfactant to remove cells;
4) washing with alkali liquor;
5) chemical bleaching agent treatment;
6) drying and sterilizing.
In the above method, particularly in step 1), the pretreatment includes an operation unit for mechanical impurity removal and brine soaking. The saline water is NaCl or KCl water solution with the mass percentage of 1-5%, and the soaking time is 0.5-12 hours.
In the above method, specifically in step 2), before the peeling, an acid treatment is performed, that is, the filter paper is sufficiently soaked with an acid solution, and then the fish skin is spread on the filter paper, so that the side containing the peeling is sufficiently contacted with the filter paper for 1-30 minutes. The acid solution is 0.1-3% acetic acid solution, or 0.1-3% citric acid solution, or 0.1-3% phosphoric acid solution, or any combination of the three. Preferably, the treatment is carried out for 5 to 10 minutes with an acetic acid solution having a concentration of 0.1 to 3%. After the scaling, the fish skin is preserved in a buffer solution with pH 6.0-8.0, preferably a phosphate buffer solution with pH 7.4.
In the above method, specifically in step 3), the surfactant solution is an aqueous solution of 0.1% to 1% of Triton × 100, 0.1% to 1% of tween 80, or 0.1% to 1% of sodium deoxycholate by mass, preferably, 0.1% to 1% of Triton × 100; the material-liquid ratio of the washing is 1:10-1:30(w/v), the oscillation speed is 100-250rpm, and the washing time is 2-48 hours.
In the above method, particularly in step 4), the alkali solution is 0.05M to 0.2M NaOH, 0.05M to 0.2M KOH or 0.05M to 0.2M ammonia solution, preferably 0.05M to 0.2M NaOH; the material-liquid ratio of the alkali liquor washing is 1:10-1:30(w/v), the oscillation speed is 100-250rpm, and the washing time is 2-24 hours.
In the method, in step 5), the chemical bleaching agent is an aqueous solution containing 0.5-5% by mass of hydrogen peroxide or an ethanol solution containing 0.5-5% by mass of peroxyacetic acid, the ratio of the chemical bleaching agent to the treated solution is 1:10-1:30(w/v), the oscillation speed is 0-250rpm, and the treatment time is 1-5 hours. Preferably, the treatment is carried out with an aqueous solution of 0.5-5% hydrogen peroxide for 3 hours.
In the above method, specifically in step 6), the sterilization method is ethylene oxide sterilization, cobalt 60 irradiation sterilization or low-temperature plasma irradiation sterilization. Preferably, ethylene oxide sterilization is used in order to reduce damage to the product from irradiation.
In addition, the application of the acellular fish skin matrix produced by the invention and the application of the acellular fish skin matrix as a wound dressing is also within the protection scope of the invention. The wound dressing has the functional activity of promoting wound healing and epithelization of new tissues.
In a word, the preparation method of the acellular fishskin matrix of tilapia fishskin provided by the invention has the following technical advantages:
(1) compared with cold water fishes such as cod and the like, the tilapia skin has the advantages of wide source, traceable raw materials, higher thermal stability, better and excellent mechanical property and quality controllability;
(2) compared with the biological material from terrestrial animals, the tilapia skin has no risk of spreading viruses with zoonosis, has no limitation of religious contraindication, has lower production cost and can greatly reduce the medical cost of patients;
(3) the innovative scale coat removing technology integrates acid liquor soaking, mechanical scraping and chemical bleaching treatment, and on the premise of keeping the original mechanical performance of the fish skin, the black scale coat and the residual fish meat and fat are removed more thoroughly, so that the clinical practicability and safety of the product are improved;
(4) the surfactant, strong base and hydrogen peroxide are comprehensively adopted for virus inactivation treatment, so that the risk of residual viruses of the animal-derived medical material is reduced.
Drawings
FIG. 1 is a photograph of a real object of a decellularized fish skin matrix, which is a front photograph.
FIG. 2 is a scanning electron micrograph of the front surface of the acellular fish skin matrix.
FIG. 3 is a scanning electron micrograph of a cross-section of a decellularized fish skin matrix showing a multilayered fibrous structure.
FIG. 4 is a photograph of H & E staining of decellularized fish skin matrix at 40-fold magnification. Collagen fibers were arranged in bundles, and no nuclei were observed to remain therein.
FIG. 5 is a photograph of H & E staining at 40X magnification with some inflammatory cells and new capillaries infiltrated therein, of a decellularized fish skin matrix implanted subcutaneously in rats for 2 weeks.
FIG. 6 is a photograph of H & E staining at 40X magnification of a decellularized fish skin matrix implanted 4 weeks under the skin of rats with some fibroblasts growing into the interior of the sample.
Fig. 7 is a general observation of the experiment of acute wound on the back skin of rats with acellular fishskin matrix, showing wound healing of fishskin acellular matrix dressing, commercially available pigskin dressing and gauze dressing at 1 week, 2 weeks and 3 weeks after surgery.
Detailed Description
The experimental methods used in the following examples are all conventional methods unless otherwise specified; the materials, reagents and the like used are commercially available unless otherwise specified. Unless otherwise specified, the concentration of a solution prepared with a liquid is expressed in terms of volume ratio (v/v), the concentration of a solution prepared with a solid is expressed in terms of weight to volume ratio (w/v), and the unit form of the mass to volume ratio described herein is g/mL.
Example 1A method for preparing a acellular fish skin matrix
1. Pretreatment
Taking 100g of fresh tilapia skin, removing scales, residual meat and fat, soaking with 1% NaCl at 15 ℃ for 6 hours at a material-liquid ratio of 1:10(w/v), repeating the steps once, and draining. The step is mainly to remove the stains on the surface of the fish skin by a mechanical method, thereby being beneficial to the subsequent operation.
2. Descaling clothes
First, a piece of filter paper is taken to be fully soaked in 0.1% acetic acid solution, then fish skin is spread on the filter paper, the side containing the scaly clothing is fully contacted with the filter paper, the fish skin is taken out after 15 minutes, the black scaly clothing is scraped by a knife until the scaly clothing is basically scraped clean, and the fish skin is temporarily stored in phosphate buffer solution with pH7.4 after being rinsed for 3 times by pure water.
3. Surfactant washing
Draining the fish skin, adding 0.1% Triton X100 (w/w) solution at a ratio of 1:10(w/v), shaking at 15 deg.C and 100rpm for 24 hr, draining, rinsing with pure water for 3 times, and draining. This step can serve as a decellularization.
4. Washing with alkaline solution
Adding 0.05M NaOH solution into the fish skin, wherein the feed-liquid ratio is 1:10(w/v), oscillating at 15 ℃ and 200rpm for 24 hours, and draining; rinsed 3 times with purified water and drained again. The step can play a role in decellularizing, removing antigen substances such as hybrid protein and the like, inactivating viruses and the like.
5. Bleaching
A0.5% hydrogen peroxide solution was added to the skin of a fish in a feed-to-solution ratio of 1:10(w/v), and the mixture was shaken at 100rpm for 3 hours at 15 ℃ and then drained, followed by rinsing 3 times with pure water and draining. This step, in addition to the bleaching function, also serves a certain virus inactivation.
6. Post-treatment
Freeze-drying the fish skin in a vacuum freeze-drying machine for 48 hours, and finally sterilizing by ethylene oxide.
Example 2A method for preparing a acellular fish skin matrix
1. Pretreatment
Taking 100g of frozen tilapia skin, thawing, soaking with 5% NaCl at 10 ℃ for 0.5 hour, the material-liquid ratio is 1:30(w/v), repeating the steps once, and draining.
2. Descaling clothes
Firstly, taking a piece of filter paper to be fully soaked in 3% citric acid solution, then spreading fish skin on the filter paper to enable one side containing the scale to be fully contacted with the filter paper, taking out after 1 minute, scraping the black scale with a knife until the scale is basically scraped clean, rinsing with pure water for 3 times, and temporarily storing in MES buffer solution with pH 6.0.
3. Surfactant washing
Adding 1% Tween 80(w/w) solution into fish skin at a ratio of 1:30(w/v) at 10 deg.C, shaking at 250rpm for 2 hr, draining, rinsing with pure water for 3 times, and draining.
4. Washing with alkaline solution
Adding 0.2M KOH solution into the fish skin, wherein the material-liquid ratio is 1:30(w/v), oscillating at 10 ℃ and 250rpm for 2 hours, and draining; rinsed 3 times with purified water and drained again.
5. Bleaching
Adding 5% hydrogen peroxide solution into fish skin at a ratio of 1:30(w/v), standing at 10 deg.C for 1 hr, draining, rinsing with pure water for 3 times, and draining.
6. Post-treatment
Freeze-drying the fish skin in a vacuum freeze-drying machine for 36 hours, and finally performing irradiation sterilization by cobalt 60 to obtain the fish skin.
Example 3A method for preparing a acellular fish skin matrix
1. Pretreatment
Taking 100g of new tilapia skin, removing scales, residual meat and fat, soaking with 3% KCl at 20 ℃ for 12 hours at a feed-liquid ratio of 1:20(w/v), repeating the steps once, and draining.
2. Descaling clothes
Firstly, taking a piece of filter paper to be fully soaked in 0.6% acetic acid solution, then spreading fish skin on the filter paper, fully contacting one side containing the scaly clothing with the filter paper, taking out after 5 minutes, scraping the black scaly clothing by using a knife until the scaly clothing is basically scraped clean, rinsing with pure water for 3 times, and temporarily storing in Tris-HCl buffer solution with the pH value of 8.0.
3. Surfactant washing
Adding 0.3% sodium deoxycholate solution into fish skin at a ratio of 1:20(w/v) at 20 deg.C, shaking at 175rpm for 48 hr, draining, rinsing with pure water for 3 times, and draining.
4. Washing with alkaline solution
Adding 0.1M ammonia water solution into fish skin at a feed-liquid ratio of 1:20(w/v), oscillating at 175rpm for 12 hours at 20 ℃, and draining; then rinsed 3 times with pure water and drained.
5. Bleaching
Adding ethanol solution containing 1% peroxyacetic acid into fish skin at a ratio of 1:20(w/v), treating at 20 deg.C for 5 hr, draining, rinsing with pure water for 3 times, and draining.
6. Post-treatment
Freeze-drying the fish skin in a vacuum freeze-drying machine for 72 hours, and finally sterilizing by low-temperature plasma irradiation.
Example 4 basic Performance assays of acellular Fish skin matrices
The acellular fish skin matrix prepared by the invention is odorless, tasteless and white flake (figure 1), and shows that black scales and stains of a sample are thoroughly removed after the scales are scraped by acid treatment and chemically bleached; scanning electron micrographs of sample cross sections revealed multilayer fiber architecture (fig. 2); the samples were paraffin embedded, sectioned, H & E stained and their loose and ordered arrangement of collagen fibers in the samples was observed without residual nuclei (fig. 3); the DNA residue was determined according to the method specified in YY/T0606.25-2014, resulting in 1.39. + -. 0.69ng residual DNA per mg of dry sample.
Example 5 comparison of thermal stability and mechanical Properties of different acellular dermal matrices
The tilapia skin was replaced by cod skin, a decellularized cod skin matrix was prepared by the method described in example 1, and the performance advantages of the tilapia skin decellularized matrix prepared in example 1 were examined by using a commercially available pigskin dressing as a control:
1. and (3) denaturation temperature: measuring with differential scanning calorimetry, accurately weighing 5mg sample, thoroughly wetting with normal saline, placing in aluminum crucible, covering, sealing, heating from 20 deg.C to 80 deg.C with empty crucible as reference, and measuring with temperature rate of 2 deg.C/mi n and nitrogen flow of 20mL/mi n.
2. Tensile strength: the sample was cut into a dumbbell-shaped specimen, sufficiently wetted with physiological saline, and the tensile strength was measured on an electronic universal tester with the tensile speed set at 15mm/mi n.
The results show that (table 1) the denaturation temperature and the mechanical strength of the tilapia mossambica sample are obviously higher than those of the cod sample and are very close to those of the pigskin dressing, which shows that the tilapia mossambica skin has certain advantages as a raw material of an acellular dermal matrix in a plurality of aquatic products and is expected to replace a pigskin dressing product.
TABLE 1 comparison of acellular skin matrix Performance of Tilapia and cod
Example 6 evaluation of biocompatibility of acellular fishskin matrix
The acellular fish skin matrix was evaluated for cytotoxicity against L929 fibroblasts, hemolysis against rabbit ear arterial blood, and local reactions to subcutaneous implantation in the back of SD rats according to the method described in GB/T16886; the results showed that the cytotoxicity was grade 0, the hemolysis rate was 1.2%, the inflammatory response was mild at 2 weeks of subcutaneous implantation in rats, a large number of neovascularization occurred (FIG. 5), a large number of fibroblasts infiltrated the interior of the sample at 4 weeks of implantation (FIG. 6), and the cells were completely absorbed at 12 weeks of implantation. Therefore, the acellular fish skin matrix prepared by the invention has good biocompatibility and meets the regulatory requirements of dressing medical instruments.
Example 7 rat dorsal skin acute wound repair wound animal experiment with acellular fishskin matrix
In the experiment, the acellular fish skin matrix prepared in the embodiment 1 is soaked in sterile normal saline for 10min in advance, and is cut into 2cm multiplied by 2cm slices for use when being implanted. And a product on the market of the pigskin dressing is used as a positive control, and the sterile gauze dressing is used as a negative control.
The specific operation is as follows: 18 SD rats are male, the weight is 200-. After operation, 6 animals of the corresponding group were sacrificed at three time points (1 week, 2 weeks, 3 weeks), the wound area was measured to calculate the wound healing rate, and skin tissue of the wound area was taken and H & E staining was used to measure the neoepithelium length.
The experimental result shows that compared with the pigskin dressing and the gauze dressing, the acellular fish skin matrix dressing group has the advantages that the inflammatory response is slight, the arrangement of collagen fibers is orderly, the swelling degree of granulation tissues at the 1 st week is the lowest, the newly born epithelia at the 2 nd week is the most, the wound healing rate at the 3 rd week is 97.72%, the wound healing rate is obviously superior to 86.65% of the gauze dressing group and is equivalent to 97.27% of the pigskin dressing group, the wound healing promoting effect is very obvious in the final stage of wound (fig. 7), and the clinical development value is high.
While particular embodiments of the present invention have been described, it will be understood by those skilled in the art that various changes and substitutions may be made thereto without departing from the spirit and scope of the invention. Such modifications and substitutions are intended to be included within the scope of the present invention as defined by the appended claims.
Claims (12)
1. A method for preparing a tilapia skin acellular dermal matrix specifically comprises the following steps:
1) washing tilapia skin to remove impurities and other pretreatment;
2) scraping off the scale coat after acid treatment;
3) washing with a surfactant to remove cells;
4) washing with alkali liquor;
5) chemical bleaching agent treatment;
6) drying and sterilizing.
2. The method of claim 1, wherein: in the step 1), the pretreatment comprises an operation unit for mechanical impurity removal and brine soaking.
3. The method of claim 2, wherein: the saline water is NaCl or KCl water solution with the mass percentage of 1-5%, and the soaking time is 0.5-12 hours.
4. The method of claim 1, wherein: in the step 2), before the scale is scraped, acid treatment is carried out, namely, the water-absorbable material is fully soaked by acid solution, then the fish skin is spread on the water-absorbable material, and the side containing the scale is fully contacted with the filter paper for 1-30 minutes.
5. The method of claim 4, wherein: the material capable of absorbing water is filter paper; the acid solution is 0.1-3% acetic acid solution, citric acid solution or phosphoric acid solution, or any combination of the three.
6. The method of claim 1, wherein: in step 2), after scaling, the fish skin is preserved in a buffer solution with pH value of 6.0-8.0.
7. The method of claim 1, wherein: in the step 3), the surfactant solution is 0.1-1% aqueous solution of Triton X100, Tween 80 or sodium deoxycholate by mass percent, the washing material-liquid ratio is 1:10-1:30(w/v), the oscillation speed is 100-.
8. The method of claim 1, wherein: in the step 4), the alkali liquor is NaOH, KOH or ammonia water solution with the molar concentration of 0.05M-0.2M, the material-liquid ratio of the alkali liquor washing is 1:10-1:30(w/v), the oscillation speed is 100-250rpm, and the washing time is 2-24 hours.
9. The method of claim 1, wherein: in the step 5), the chemical bleaching agent is an aqueous solution of hydrogen peroxide with the mass percentage of 0.5-5% or an ethanol solution of peroxyacetic acid with the mass percentage of 0.5-5%, the ratio of the chemical bleaching agent to the treated material liquid is 1:10-1:30(w/v), the oscillation speed is 0-250rpm, and the treatment time is 1-5 hours.
10. The method of claim 1, wherein: in step 6), the sterilization method is ethylene oxide sterilization.
11. Use of the acellular fish skin matrix prepared according to the method of claim 1 in wound dressings.
12. Use according to claim 11, characterized in that: the wound dressing has the functions of promoting wound healing and new epithelization.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811232737.0A CN111084900A (en) | 2018-10-23 | 2018-10-23 | Preparation method and application of acellular fish skin matrix |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811232737.0A CN111084900A (en) | 2018-10-23 | 2018-10-23 | Preparation method and application of acellular fish skin matrix |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111084900A true CN111084900A (en) | 2020-05-01 |
Family
ID=70392502
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811232737.0A Pending CN111084900A (en) | 2018-10-23 | 2018-10-23 | Preparation method and application of acellular fish skin matrix |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111084900A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114642624A (en) * | 2020-12-21 | 2022-06-21 | 颜荣宏 | Refined amino acid biological carrier mask and the use of refined amino acid in skin care products |
CN114949330A (en) * | 2022-06-16 | 2022-08-30 | 国科温州研究院(温州生物材料与工程研究所) | Acellular fish skin matrix and preparation method thereof |
CN115869453A (en) * | 2021-09-26 | 2023-03-31 | 中国科学院理化技术研究所 | A double-layer antibacterial dressing loaded with antibacterial molecules, its preparation and application |
CN116650723A (en) * | 2023-07-06 | 2023-08-29 | 苏州微创再生医学科技有限公司 | Fish skin-based biological patch, preparation method thereof and medical material |
JP2024513169A (en) * | 2021-03-25 | 2024-03-22 | ケレシス フルタフェラク | Wound treatments and methods for stabilizing, protecting, and treating wounds - Patents.com |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102781485A (en) * | 2009-10-07 | 2012-11-14 | 克雷西斯公司 | A scaffold material for wound care and/or other tissue healing applications |
CN105755078A (en) * | 2014-12-19 | 2016-07-13 | 山东国际生物科技园发展有限公司 | Preparation method and application of medical grade fish skin collagens |
-
2018
- 2018-10-23 CN CN201811232737.0A patent/CN111084900A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102781485A (en) * | 2009-10-07 | 2012-11-14 | 克雷西斯公司 | A scaffold material for wound care and/or other tissue healing applications |
CN105755078A (en) * | 2014-12-19 | 2016-07-13 | 山东国际生物科技园发展有限公司 | Preparation method and application of medical grade fish skin collagens |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114642624A (en) * | 2020-12-21 | 2022-06-21 | 颜荣宏 | Refined amino acid biological carrier mask and the use of refined amino acid in skin care products |
JP2024513169A (en) * | 2021-03-25 | 2024-03-22 | ケレシス フルタフェラク | Wound treatments and methods for stabilizing, protecting, and treating wounds - Patents.com |
CN115869453A (en) * | 2021-09-26 | 2023-03-31 | 中国科学院理化技术研究所 | A double-layer antibacterial dressing loaded with antibacterial molecules, its preparation and application |
CN114949330A (en) * | 2022-06-16 | 2022-08-30 | 国科温州研究院(温州生物材料与工程研究所) | Acellular fish skin matrix and preparation method thereof |
CN114949330B (en) * | 2022-06-16 | 2024-02-20 | 国科温州研究院(温州生物材料与工程研究所) | Acellular fishskin matrix and preparation method thereof |
CN116650723A (en) * | 2023-07-06 | 2023-08-29 | 苏州微创再生医学科技有限公司 | Fish skin-based biological patch, preparation method thereof and medical material |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111084900A (en) | Preparation method and application of acellular fish skin matrix | |
US10426868B2 (en) | Method for preparing an animal decellularized tissue matrix material and a decellularized tissue matrix material prepared thereby | |
CN107233613B (en) | Aquatic organism source cross-linked collagen composite multilayer medical dressing | |
JP4615223B2 (en) | Collagen biofiber and its preparation method and use | |
CN105797212B (en) | A kind of de- cell amnion preparation method and application for the refractory conjunction wound repair of skin | |
CN106492285A (en) | Injectable Acellular cartilaginous matrix particulate and its application in implant | |
CN104055795B (en) | A kind of injectable implant and preparation method thereof | |
CN109675112B (en) | Preparation method of human-derived acellular dermal matrix | |
CN101773687B (en) | Preparation method of composite soft-tissue patch | |
CN107551312B (en) | Flocculent collagen hemostatic fiber and preparation method thereof | |
CN112755247B (en) | Acellular dermal matrix and preparation method thereof | |
CN108888804B (en) | Soft tissue repair material and preparation method thereof | |
CN109364298A (en) | A kind of preparation method of acellular dermal matrix material | |
CN106390209A (en) | Silk fibroin biological material compounded with epidermal growth factor and preparation method of silk fibroin biological material | |
CN112618799A (en) | Fish skin acellular dermal matrix and preparation method and application thereof | |
JPH04501077A (en) | Preparation method of bovine pericardium material and its uses | |
CN103961752B (en) | Tissue regeneration guiding film and preparation method thereof | |
CN115747993A (en) | Collagen fiber with high biocompatibility and high stability, and preparation method and application thereof | |
KR101455837B1 (en) | Process for preparing resorbable barrier membrane for guided tissue regeneration | |
US20050214374A1 (en) | Artificial extracellular matrix and process for producing the same | |
CN113244439A (en) | Antigen-free collagen aggregate and preparation method thereof | |
RU2353397C2 (en) | Bioabsorbable collagen matrix, method of production and application | |
CN108079363A (en) | A kind of kit and its application that cell processing is taken off for animal tissue | |
CN114306755B (en) | Biological patch for posterior scleral reinforcement and preparation method thereof | |
CN109550075A (en) | A kind of preparation method of pigskin acellular dermal matrix dressing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200727 Address after: No.39, Keji Avenue, Yantai hi tech Zone, Yantai City, Shandong Province Applicant after: YANTAI LANCHUANG BIOTECHNOLOGY Co.,Ltd. Address before: 264670 No. 39, science and technology Avenue, hi tech Zone, Shandong, Yantai Applicant before: SHANDONG INTERNATIONAL BIOTECHNOLOGY PARK DEVELOPMENT Co.,Ltd. Applicant before: YANTAI LANCHUANG BIOTECHNOLOGY Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200501 |
|
RJ01 | Rejection of invention patent application after publication |